Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

Clinical trial NCT06787014 · RECRUITING

Trial details

NCT number: NCT06787014
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Study type: OBSERVATIONAL

Neuroendocrine (NE) Tumors Metastasis Bowel Obstruction

Start date: 2026-03-09
Primary completion: 2026-03-09
Enrollment: 3200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.